de Voux Alex, Kidd Sarah, Grey Jeremy A, Rosenberg Eli S, Gift Thomas L, Weinstock Hillard, Bernstein Kyle T
MMWR Morb Mortal Wkly Rep. 2017 Apr 7;66(13):349-354. doi: 10.15585/mmwr.mm6613a1.
In 2015, the rate of reported primary and secondary syphilis in the United States was 7.5 cases per 100,000 population, nearly four times the previous lowest documented rate of 2.1 in 2000 (1). In 2015, 81.7% of male primary and secondary syphilis cases with information on the sex of the sex partner were among gay, bisexual, and other men who have sex with men (collectively referred to as MSM) (1). These data suggest a disproportionate incidence of disease among MSM. However, attempts to quantify this disparity have been hindered by limited data on the size of the MSM population at the state level. To produce the first estimates of state-specific rates of primary and secondary syphilis among MSM, CDC used MSM population estimates based on a new methodology (2) and primary and secondary syphilis case counts reported in 2015 to the National Notifiable Diseases Surveillance System. Among 44 states reporting information on the sex of sex partners for ≥70% of male cases, the overall rate of primary and secondary syphilis among all men (aged ≥18 years) in the United States in 2015 was 17.5 per 100,000, compared with 309.0 among MSM and 2.9 among men who reported sex with women only. The overall rate of primary and secondary syphilis among MSM was 106.0 times the rate among men who have sex with women only and 167.5 times the rate among women.* These data highlight the disproportionate impact of syphilis among MSM and underscore the need for innovative and targeted syphilis prevention measures at the state and local level, especially among MSM. It is important that health care providers recognize the signs and symptoms of syphilis, screen sexually active MSM for syphilis at least annually, and provide timely treatment according to national sexually transmitted diseases treatment guidelines (3).
2015年,美国报告的一期和二期梅毒发病率为每10万人中有7.5例,几乎是2000年有记录以来最低发病率2.1例的四倍(1)。2015年,在有性伴侣性别信息的男性一期和二期梅毒病例中,81.7%发生在男同性恋、双性恋及其他与男性发生性行为的男性(统称为男男性行为者,即MSM)中(1)。这些数据表明梅毒在男男性行为者中的发病率不成比例。然而,由于州一级男男性行为者群体规模的数据有限,量化这种差异的尝试受到了阻碍。为了得出男男性行为者中一期和二期梅毒的各州特定发病率的首次估计值,美国疾病控制与预防中心(CDC)使用了基于新方法的男男性行为者群体估计值(2)以及2015年向国家法定传染病监测系统报告的一期和二期梅毒病例数。在44个报告了≥70%男性病例性伴侣性别的州中,2015年美国所有男性(年龄≥18岁)中一期和二期梅毒的总体发病率为每10万人中有17.5例,而男男性行为者中的发病率为每10万人中有309.0例,仅与女性发生性行为的男性中的发病率为每10万人中有2.9例。男男性行为者中一期和二期梅毒的总体发病率是仅与女性发生性行为的男性发病率的106.0倍,是女性发病率的167.5倍。*这些数据凸显了梅毒在男男性行为者中的不成比例影响,并强调了在州和地方层面采取创新和有针对性的梅毒预防措施的必要性,尤其是在男男性行为者中。医疗保健提供者认识到梅毒的体征和症状、至少每年对性活跃的男男性行为者进行梅毒筛查,并根据国家性传播疾病治疗指南(3)及时提供治疗非常重要。